PA
SFD

PharVision Advisers’s Smithfield Foods SFD Stock Holding History

PharVision Advisers’s Portfolio SFD Stock Details SFD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-10,394
Closed -$232K – 690
2025
Q4 		$232K Sell
10,394
-4,176
-29% -$91.9K 0.12% 437
2025
Q3 		$342K Buy
+14,570
New +$356K 0.19% 152

Other funds holding SFD

Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
FSC
Fourth Sail Capital Camana Bay Grand Cayman, Cayman Islands $608M AUM 48.69% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

PharVision Advisers's SFD Position: Q1 2026 in Review

PharVision Advisers sold out of Smithfield Foods (SFD) in Q1 2026, closing a stake of 10,394 shares — an estimated $232K sold.

PharVision Advisers first reported a position in SFD in Q3 2025 and held it in 2 quarters. The position peaked at $342K in Q3 2025. 243 funds tracked by Wall St. Rank hold SFD as of Q1 2026.

  • PharVision Advisers reported no remaining Smithfield Foods position as of Q1 2026 after selling out during the quarter.
  • PharVision Advisers sold 10,394 Smithfield Foods shares in Q1 2026, an estimated $232K.
  • PharVision Advisers first reported a position in Smithfield Foods in Q3 2025 and held it in 2 quarters.
  • PharVision Advisers's Smithfield Foods position peaked at $342K in Q3 2025.
  • 243 funds tracked by Wall St. Rank held Smithfield Foods as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.